Ahmed Goolam
Research Subjects
Ahmed Goolam has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Chung
Department of Urology, Royal North Shore Hospital, Sydney, NSW 2065, Australia
1 shared publication - Andrew Shepherd
Department of Urology, Royal North Shore Hospital, Sydney 2065, Australia
1 shared publication - Ankur Dhar
Westmead Hospital Sydney New South Wales Australia
1 shared publication - James Kovacic
North Shore Urology Research Group, Sydney, Australia
1 shared publication - Jonathan Kam
School of Medicine, The University of Sydney, Sydney, Australia
1 shared publication - Matthew Winter
North Shore Urology Research Group, Sydney, Australia
1 shared publication
Latest Publications
- Open Access
- 11 April 2025
- Published by Wolters Kluwer Health in Current Urology
- Vol. 19 (4) , 286-292
Salvage robotic-assisted radical cystectomy is safe in patients with history of pelvic irradiation
Objectives: To describe the surgical approach and perioperative outcomes of a multicenter series evaluating a robotic-assisted approach to radical cystectomy with total intracorporeal urinary diversion in the setting of prior pelvic radiotherapy. Materials and methods: We analyzed our prospective cystectomy database for patients who underwent robotic-assisted radical cystectomy for bladder cancer after radiotherapy between 2018 and 2022. Demographic information and data regarding preoperative factors including stage of disease, preoperative hydronephrosis, and history of pelvic radiotherapy were collected via review of electronic medical records. All operations were performed by 1 of 2 experienced urologists using the da Vinci X, Xi, or Si surgical platforms. Results: Ten patients were identified for this study. The median age of participants was 73.5 years (range, 41–84 years). The median American Society of Anesthesiologists classification score was 3 (range, 3–4). The median Charlson Comorbidity Index was 6 (range, 2–12). Among the patients, 4 out of 10 patients (40%) had muscle invasive bladder cancer before salvage surgery. Intracorporeal ileal conduit urinary diversion was performed in 8 patients, whereas 2 patients underwent intracorporeal neobladder formation. Median intraoperative blood loss was 250 mL (range, 150–600 mL), and median operative duration was 390 minutes (range, 195–450 minutes). The overall 30-day complication rate was 60% with a Clavien-Dindo grade ≥3 complication rate of 15%. Perioperative mortality was 0%. Median duration of follow-up was 210 days (range, 60–1580 days). Conclusions: This series describing the outcomes of salvage robotic-assisted radical cystectomy using total intracorporeal urinary diversion demonstrates the safety of this technique. Further studies with long-term follow-up, including oncological outcomes, are required to support the widespread adoption of this procedure.
- 11 April 2025
- Published by Wolters Kluwer Health in Current Urology
- Vol. 19 (4) , 286-292
Open AccessSalvage robotic-assisted radical cystectomy is safe in patients with history of pelvic irradiation
Objectives: To describe the surgical approach and perioperative outcomes of a multicenter series evaluating a robotic-assisted approach to radical cystectomy with total intracorporeal urinary diversion in the setting of prior pelvic radiotherapy. Materials and methods: We analyzed our prospective cystectomy database for patients who underwent robotic-assisted radical cystectomy for bladder cancer after radiotherapy between 2018 and 2022. Demographic information and data regarding preoperative factors including stage of disease, preoperative hydronephrosis, and history of pelvic radiotherapy were collected via review of electronic medical records. All operations were performed by 1 of 2 experienced urologists using the da Vinci X, Xi, or Si surgical platforms. Results: Ten patients were identified for this study. The median age of participants was 73.5 years (range, 41–84 years). The median American Society of Anesthesiologists classification score was 3 (range, 3–4). The median Charlson Comorbidity Index was 6 (range, 2–12). Among the patients, 4 out of 10 patients (40%) had muscle invasive bladder cancer before salvage surgery. Intracorporeal ileal conduit urinary diversion was performed in 8 patients, whereas 2 patients underwent intracorporeal neobladder formation. Median intraoperative blood loss was 250 mL (range, 150–600 mL), and median operative duration was 390 minutes (range, 195–450 minutes). The overall 30-day complication rate was 60% with a Clavien-Dindo grade ≥3 complication rate of 15%. Perioperative mortality was 0%. Median duration of follow-up was 210 days (range, 60–1580 days). Conclusions: This series describing the outcomes of salvage robotic-assisted radical cystectomy using total intracorporeal urinary diversion demonstrates the safety of this technique. Further studies with long-term follow-up, including oncological outcomes, are required to support the widespread adoption of this procedure.
- Open Access
- 25 September 2023
- Published by Wolters Kluwer Health in Current Urology
- Vol. 18 (4) , 342-343
Robot-assisted ileocystoplasty for the treatment of adult neurogenic bladder: A video demonstration and outcomes
Ileocystoplasty is one of the treatment options in the armamentarium for the management of adults with neurogenic bladder dysfunction, after failure of less invasive treatment alternatives, such as intravesical onabotulinum toxin A injection therapy and sacral neuromodulation. It has traditionally been performed as open surgery and can be associated with significant morbidity, especially in the early postoperative period. [1] Complications associated with open ileocystoplasty include prolonged postoperative ileus, wound infections, and pain. Performing robot-assisted ileocystoplasty can reduce the morbidity associated with open surgery [2] and has been shown to be safe and feasible in experienced hands, [3] although it may be associated with increased operative duration because of its learning curve. Our technique of robot-assisted ileocystoplasty and early postoperative outcomes is demonstrated in this video (Supplemental Digital Content, http://links.lww.com/CURRUROL/A47). Robotic console time was 180 minutes, with minimal blood loss. Eight-hourly catheter aspiration and flushes were performed to manage the mucus in the urine. There were no metabolic acidosis or electrolyte derangements postoperatively. The patient was discharged on postoperative day 5. Postoperative cystogram at week 2 showed no leak and the patient is doing well at 1 year postoperatively. Robotic ileocystoplasty is safe and feasible and can reduce the morbidity associated with open surgery with good outcomes.
- 25 September 2023
- Published by Wolters Kluwer Health in Current Urology
- Vol. 18 (4) , 342-343
Open AccessRobot-assisted ileocystoplasty for the treatment of adult neurogenic bladder: A video demonstration and outcomes
Ileocystoplasty is one of the treatment options in the armamentarium for the management of adults with neurogenic bladder dysfunction, after failure of less invasive treatment alternatives, such as intravesical onabotulinum toxin A injection therapy and sacral neuromodulation. It has traditionally been performed as open surgery and can be associated with significant morbidity, especially in the early postoperative period. [1] Complications associated with open ileocystoplasty include prolonged postoperative ileus, wound infections, and pain. Performing robot-assisted ileocystoplasty can reduce the morbidity associated with open surgery [2] and has been shown to be safe and feasible in experienced hands, [3] although it may be associated with increased operative duration because of its learning curve. Our technique of robot-assisted ileocystoplasty and early postoperative outcomes is demonstrated in this video (Supplemental Digital Content, http://links.lww.com/CURRUROL/A47). Robotic console time was 180 minutes, with minimal blood loss. Eight-hourly catheter aspiration and flushes were performed to manage the mucus in the urine. There were no metabolic acidosis or electrolyte derangements postoperatively. The patient was discharged on postoperative day 5. Postoperative cystogram at week 2 showed no leak and the patient is doing well at 1 year postoperatively. Robotic ileocystoplasty is safe and feasible and can reduce the morbidity associated with open surgery with good outcomes.